Home › NDC Lookup › RxCUI directory › RxCUI 104837

Isocarboxazid 10 MG Oral Tablet — RxCUI 104837

RxNorm drug concept · Semantic clinical drug
RxCUI 104837 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI104837
Official nameIsocarboxazid 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Isocarboxazid: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Marplan treats depression. It's usually saved for people who haven't done well on other antidepressants, because it can cause serious side effects.
  • You take the tablets by mouth, split into two to four doses a day, as your prescriber directs. They'll usually raise the dose slowly. It can take 3 to 6 weeks to feel the full bene...
  • How should I take it, and how long until it works?
  • Yes, and it's important. Foods high in tyramine can cause a dangerous blood pressure spike. These include aged or strong cheese, sour cream, beer (even non-alcoholic), Chianti, soy...
📖 Read our full Isocarboxazid guide →

🕸️ Concept Web — How Isocarboxazid 10 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Isocarboxazid 10 MG Oral Tablet RxCUI 104837

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Isocarboxazid 6011
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Marplan 152005
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Isocarboxazid Oral Tablet 370712
    • Isocarboxazid Oral Product 1159149
    • Isocarboxazid Pill 1159150
    • Isocarboxazid Oral Tablet [Marplan] 367720
    • Marplan Oral Product 1181020
    • Marplan Pill 1181021
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Isocarboxazid 10 MG SCDC · 316104
  • Isocarboxazid Oral Tablet SCDF · 370712
  • Isocarboxazid Oral Product SCDG · 1159149
  • Isocarboxazid Pill SCDG · 1159150

Brand-Name Concepts

  • Isocarboxazid 10 MG Oral Tablet [Marplan] SBD · 201708
  • Isocarboxazid 10 MG [Marplan] SBDC · 565984
  • Isocarboxazid Oral Tablet [Marplan] SBDF · 367720
  • Marplan Oral Product SBDG · 1181020
  • Marplan Pill SBDG · 1181021
  • Marplan BN · 152005

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 104837 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72336-0032-01 100 TABLET in 1 BOTTLE, PLASTIC (72336-032-01) MARPLAN Lifsa Drugs LLC 1959-07-01
Observed labelers: Lifsa Drugs LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.